Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)

Daehan Nupharm Revenue

Daehan Nupharm had revenue of 51.85B KRW in the quarter ending March 31, 2025, with 7.45% growth. This brings the company's revenue in the last twelve months to 205.78B, up 2.40% year-over-year. In the year 2024, Daehan Nupharm had annual revenue of 202.19B, down -1.00%.

• Revenue (ttm): 205.78B
• Revenue Growth: +2.40%
• P/S Ratio: 0.49
• Revenue / Employee: 902.55M
• Employees: 228
• Market Cap: 101.19B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	202.19B	-2.04B	-1.00%
Dec 31, 2023	204.22B	6.27B	3.16%
Dec 31, 2022	197.96B	31.37B	18.83%
Dec 31, 2021	166.59B	17.29B	11.58%
Dec 31, 2020	149.29B	15.20B	11.33%